Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer
The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Garofalo, M., Romano, G., Di Leva, G., Nuovo, G., Jeon, Y.-J., Ngankeu, A., Sun, J., Lovat, F., Alder, H., Condorelli, G., et al. (2012) · Nature Medicine · doi:10.1038/nm.2577 · Cited by 365
Retractedde la Cruz-Morcillo, M. A., Valero, M. L. L., Callejas-Valera, J. L., Arias-González, L., Melgar-Rojas, P., Galán-Moya, E. M., García-Gil, E., García-Cano, J., & Sánchez-Prieto, R. (2012) · Oncogene · doi:10.1038/onc.2011.321 · Cited by 117
RetractedSiegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,679
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Autophagy in Health and Disease: A Double-Edged Sword
Shintani, T., & Klionsky, D. J. (2004) · Science · doi:10.1126/science.1099993 · Cited by 2,534
Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., & Peter, M. E. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00245.x · Cited by 2,184
Chemotherapy and the war on cancer
Chabner, B. A., & Roberts, T. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1529 · Cited by 2,154
An operational definition of epigenetics: Figure 1.
Berger, S. L., Kouzarides, T., Shiekhattar, R., & Shilatifard, A. (2009) · Genes & Development · doi:10.1101/gad.1787609 · Cited by 1,884
Apoptosis control by death and decoy receptors
Ashkenazi, A., & Dixit, V. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80034-9 · Cited by 1,288
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.350 · Cited by 1,204
Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, O. W., Epstein, A. L., & Korsmeyer, S. J. (1985) · Cell · doi:10.1016/s0092-8674(85)80070-2 · Cited by 1,179
du Bois, A. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg036 · Cited by 1,113
Jansson, M. D., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,099
McDonnell, T. J., Troncoso, P., Brisbay, S. M., Logothetis, C. J., Chung, L. W. K., Hsieh, J., Tu, S., & Campbell, M. L. (1992) · PubMed · Cited by 1,049
Konopleva, M., Contractor, R., Tsao, T., Samudio, I., Ruvolo, P. P., Kitada, S., Deng, X., Zhai, D., Shi, Y.-X., Sneed, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.006 · Cited by 1,023
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Kang, M. H., & Reynolds, C. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0144 · Cited by 1,016
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
Miyashita, T., & Reed, J. (1993) · Blood · doi:10.1182/blood.v81.1.151.151 · Cited by 882
McDonnell, T. J., & Korsmeyer, S. J. (1991) · Nature · doi:10.1038/349254a0 · Cited by 858
Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R., & Kroemer, G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.22 · Cited by 842
Campos, L., Rouault, J., Sabido, O., Oriol, P., Roubi, N., Vasselon, C., Archimbaud, E., Magaud, J., & Guyotat, D. (1993) · Blood · doi:10.1182/blood.v81.11.3091.3091 · Cited by 784
Donawho, C. K., Luo, Y., Luo, Y., Penning, T. D., Bauch, J. L., Bouska, J. J., Bontcheva-Diaz, V. D., Cox, B. F., DeWeese, T. L., Dillehay, L. E., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3039 · Cited by 773
Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
Pan, R., Hogdal, L. J., Benito, J. M., Bucci, D., Han, L., Borthakur, G., Cortes, J., DeAngelo, D. J., Debose, L., Mu, H., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0609 · Cited by 735
Mechanisms of chemoresistance in cancer stem cells
Abdullah, L. N., & Chow, E. K. (2013) · Clinical and Translational Medicine · doi:10.1186/2001-1326-2-3 · Cited by 721
Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin
Go, R. S., & Adjei, A. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.409 · Cited by 697
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
Schwickart, M., Huang, X., Lill, J. R., Liu, J., Ferrando, R., French, D. M., Maecker, H., O’Rourke, K., Bazan, F., Eastham-Anderson, J., et al. (2010) · Nature · doi:10.1038/nature08646 · Cited by 628
THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.
JOHNSON, I. S., Jg, A., Gorman, M., & Jp, B. (1963) · PubMed · Cited by 564
Liu, Y., Cao, Y., Zhang, W., Bergmeier, S., Qian, Y., Akbar, H., Colvin, R., Ding, J., Tong, L., Wu, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0131 · Cited by 555
Fatty Acid Synthase As a Potential Therapeutic Target in Cancer
Flavin, R., Peluso, S., Nguyen, P. L., & Loda, M. (2010) · Future Oncology · doi:10.2217/fon.10.11 · Cited by 545
MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models
Mahon, F.-X., Belloc, F., Lagarde, V., Chollet, C., Moreau-Gaudry, F., Reiffers, J., Goldman, J. M., & Melo, J. V. (2003) · Blood · doi:10.1182/blood.v101.6.2368 · Cited by 538
DNA damage signalling guards against activated oncogenes and tumour progression
Bartek, J., Bartkova, J., & Lukas, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210881 · Cited by 521
Calabrese, C. R., Almassy, R., Barton, S., Batey, M. A., Calvert, A. H., Canan-Koch, S., Durkacz, B. W., Hostomsky, Z., Kumpf, R. A., Kyle, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh005 · Cited by 487
Imatinib: A Breakthrough of Targeted Therapy in Cancer
Iqbal, N., & Iqbal, N. (2014) · Chemotherapy Research and Practice · doi:10.1155/2014/357027 · Cited by 470
Hermine, O., Haioun, C., Lepage, E., d'Agay, M., Briere, J., Lavignac, C., Fillet, G., Salles, G., Marolleau, J., Diebold, J., et al. (1996) · Blood · doi:10.1182/blood.v87.1.265.265 · Cited by 452
BCL-2 Family Proteins: Critical Checkpoints of Apoptotic Cell Death
Danial, N. N. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1598 · Cited by 433
ABC Transporters, Drug Resistance, and Cancer Stem Cells
Dean, M. (2009) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-009-9109-9 · Cited by 425
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
Song, B., Wang, Y., Xi, Y., Kudo, K., Bruheim, S., Botchkina, G. I., Gavin, E., Wan, Y., Formentini, A., Kornmann, M., et al. (2009) · Oncogene · doi:10.1038/onc.2009.274 · Cited by 410
Bcl-2 protein expression and long-term survival in breast cancer.
Joensuu, H., Pylkkänen, L. H., & Toikkanen, S. (1994) · PubMed · Cited by 396
Zhou, M., Zhao, Y., Ding, Y., Liu, H., Liu, Z., Fodstad, O., Riker, A. I., Kamarajugadda, S., Lu, J., Owen, L. B., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-33 · Cited by 395
Choudhary, G. S., Al-harbi, S., Mazumder, S., Hill, B. T., Smith, M. R., Bodo, J., Hsi, E. D., & Almasan, A. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.525 · Cited by 390
Cancer metabolism: current perspectives and future directions
Muñoz-Pinedo, C., El Mjiyad, N., & Ricci, J.-E. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.123 · Cited by 385
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
Yecies, D., Carlson, N. E., Deng, J., & Letai, A. (2010) · Blood · doi:10.1182/blood-2009-07-233304 · Cited by 360
Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
Steg, A. D., Bevis, K. S., Katre, A. A., Ziebarth, A., Dobbin, Z. C., Alvarez, R. D., Zhang, K., Conner, M., & Landen, C. N. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2188 · Cited by 359
Yang, N., Kaur, S., Volinia, S., Greshock, J., Lassus, H., Hasegawa, K., Liang, S., Leminen, A., Deng, S., Smith, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1954 · Cited by 352
Hu, Y., Yan, C., Mu, L., Huang, K., Li, X., Tao, D., Wu, Y., & Qin, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125625 · Cited by 348
The initial clinical trial of nitrogen mustard
Gilman, A. (1963) · The American Journal of Surgery · doi:10.1016/0002-9610(63)90232-0 · Cited by 338
Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin
Evers, B., Drost, R., Schut, E., de Bruin, M., van der Burg, E., Derksen, P. W. B., Holstege, H., Liu, X., van Drunen, E., Beverloo, H. B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4953 · Cited by 335
Zhou, P., Qian, L., Kozopas, K. M., & Craig, R. W. (1997) · Blood · doi:10.1182/blood.v89.2.630 · Cited by 326
BCL2A1: the underdog in the BCL2 family
Vogler, M. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.158 · Cited by 325
FREI, E., KARON, M., LEVIN, R. H., FREIREICH, E. J., TAYLOR, R. J., HANANIAN, J., SELAWRY, O., HOLLAND, J. F., HOOGSTRATEN, B., WOLMAN, I. J., et al. (1965) · Blood · doi:10.1182/blood.v26.5.642.642 · Cited by 325
Vogler, M., Butterworth, M., Majid, A., Walewska, R. J., Sun, X.-M., Dyer, M. J. S., & Cohen, G. M. (2009) · Blood · doi:10.1182/blood-2008-08-173310 · Cited by 323
Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells
Sasaki, K., Tsuno, N. H., Sunami, E., Tsurita, G., Kawai, K., Okaji, Y., Nishikawa, T., Shuno, Y., Hongo, K., Hiyoshi, M., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-370 · Cited by 322
Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53 –Mediated Mouse Mammary Tumors
Shafee, N., Smith, C. R., Wei, S., Kim, Y., Mills, G. B., Hortobagyi, G. N., Stanbridge, E. J., & Lee, E. Y.-H. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5480 · Cited by 308
Rosell, R., Gatzemeier, U., Betticher, D. C., Keppler, U., Macha, H. N., Pirker, R., Berthet, P., Breau, J. L., Lianes, P., Nicholson, M., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf332 · Cited by 299
Placzek, W. J., Wei, J., Kitada, S., Zhai, D., Reed, J. C., & Pellecchia, M. (2010) · Cell Death & Disease · doi:10.1038/cddis.2010.18 · Cited by 294
Bae, J., Leo, C. P., Hsu, S. Y., & Hsueh, A. J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909826199 · Cited by 289
Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism
Zhao, Y., Liu, H., Liu, Z., Ding, Y., LeDoux, S. P., Wilson, G. L., Voellmy, R., Lin, Y., Lin, W., Nahta, R., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0127 · Cited by 289
Chen, D., Wu, M., Li, Y., Chang, I., Yuan, Q., Ekimyan-Salvo, M., Deng, P., Yu, B., Yu, Y., Dong, J., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.02.003 · Cited by 280
Targeting the Bcl-2 family for cancer therapy
Thomas, S., Quinn, B. A., Das, S. K., Dash, R., Emdad, L., Dasgupta, S., Wang, X.-Y., Dent, P., Reed, J. C., Pellecchia, M., et al. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.733001 · Cited by 277
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
Song, B., Wang, Y., Titmus, M. A., Botchkina, G., Formentini, A., Kornmann, M., & Ju, J. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-96 · Cited by 265
Fujita, Y., Yagishita, S., Hagiwara, K., Yoshioka, Y., Kosaka, N., Takeshita, F., Fujiwara, T., Tsuta, K., Nokihara, H., Tamura, T., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.10 · Cited by 261
Wu, C., Calcagno, A. M., & Ambudkar, S. V. (2008) · Current Molecular Pharmacology · doi:10.2174/1874-470210801020093 · Cited by 259
Han, W., Pan, H., Chen, Y., Sun, J., Wang, Y., Li, J., Ge, W., Feng, L., Lin, X., Wang, X., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018691 · Cited by 256
Mitochondrial signaling in cell death via the Bcl-2 family
Leibowitz, B., & Yu, J. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.6.11392 · Cited by 247
Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy
Sieghart, W., Losert, D., Strommer, S., Cejka, D., Schmid, K., Rasoul-Rockenschaub, S., Bodingbauer, M., Crevenna, R., Monia, B. P., Peck-Radosavljevic, M., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.010 · Cited by 244
Targeting cancer stem cells to suppress acquired chemotherapy resistance
Vidal, S. J., Rodriguez-Bravo, V, Galsky, M., Cordon-Cardo, C., & Domingo-Domenech, J. (2014) · Oncogene · doi:10.1038/onc.2013.411 · Cited by 242
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
Bockhorn, J., Dalton, R., Nwachukwu, C., Huang, S., Prat, A., Yee, K., Chang, Y.-F., Huo, D., Wen, Y., Swanson, K. E., et al. (2013) · Nature Communications · doi:10.1038/ncomms2393 · Cited by 237
(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407173-5.00003-0 · Cited by 223
Cao, X., Fang, L., Gibbs, S., Huang, Y., Dai, Z., Wen, P., Zheng, X., Sadee, W., & Sun, D. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0291-9 · Cited by 221
Error-prone translesion synthesis mediates acquired chemoresistance
Xie, K., Doles, J., Hemann, M. T., & Walker, G. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011412107 · Cited by 219
Liu, H., Liu, Y., & Zhang, J.-T. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0445 · Cited by 216
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells
Hulleman, E., Kazemier, K. M., Holleman, A., VanderWeele, D. J., Rudin, C. M., Broekhuis, M. J. C., Evans, W. E., Pieters, R., & Den Boer, M. L. (2009) · Blood · doi:10.1182/blood-2008-05-157842 · Cited by 213
Molecular Pharmacology of ABCG2 and Its Role in Chemoresistance
Stacy, A. E., Jansson, P. J., & Richardson, D. R. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088609 · Cited by 210
Sartorius, U. A., & Krammer, P. H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10096 · Cited by 207
Targeting Mcl-1 for the therapy of cancer
Quinn, B. A., Dash, R., Azab, B., Sarkar, S., Das, S. K., Kumar, S., Oyesanya, R. A., Dasgupta, S., Dent, P., Grant, S., et al. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.609167 · Cited by 202
McBrayer, S. K., Cheng, J. C., Singhal, S., Krett, N. L., Rosen, S. T., & Shanmugam, M. (2012) · Blood · doi:10.1182/blood-2011-09-377846 · Cited by 192
Doles, J., Oliver, T. G., Cameron, E. R., Hsu, G., Jacks, T., Walker, G. C., & Hemann, M. T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011409107 · Cited by 190
Therapy of Choriocarcinoma and Related Trophoblastic Tumors with Folic Acid and Purine Antagonists
Li, M. C., Hertz, R., & Bergenstal, D. M. (1958) · New England Journal of Medicine · doi:10.1056/nejm195807102590204 · Cited by 189
Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia
Lin, K. H., Winter, P. S., Xie, A., Roth, C., Martz, C. A., Stein, E. M., Anderson, G. R., Tingley, J. P., & Wood, K. C. (2016) · Scientific Reports · doi:10.1038/srep27696 · Cited by 186
Target for cancer therapy: proliferating cells or stem cells
Blagosklonny, M. V. (2006) · Leukemia · doi:10.1038/sj.leu.2404075 · Cited by 184
Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease
Williams, J., Lucas, P. C., Griffith, K. A., Choi, M., Fogoros, S., Hu, Y. Y., & Liu, J. R. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.10.026 · Cited by 173
A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non–Small-Cell Lung Cancer
Goldberg, S. B., Supko, J. G., Neal, J. W., Muzikansky, A., Digumarthy, S., Fidias, P., Temel, J. S., Heist, R. S., Shaw, A. T., McCarthy, P. O., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318262de4a · Cited by 170
Cancer Metabolism and Drug Resistance
Rahman, M., & Hasan, M. (2015) · Metabolites · doi:10.3390/metabo5040571 · Cited by 170
Overcoming Multidrug Resistance in Cancer Stem Cells
Moitra, K. (2015) · BioMed Research International · doi:10.1155/2015/635745 · Cited by 169
The Relationship Between Dormant Cancer Cells and Their Microenvironment
(2016) · Advances in Cancer Research · doi:10.1016/bs.acr.2016.07.002 · Cited by 162
Shintani, Y., Okimura, A., Sato, K., Nakagiri, T., Kadota, Y., Inoue, M., Sawabata, N., Minami, M., Ikeda, N., Kawahara, K., et al. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.07.032 · Cited by 159
Ghuwalewala, S., Ghatak, D., Das, P. K., Dey, S., Sarkar, S., Alam, N., Panda, C. K., & Roychoudhury, S. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.02.028 · Cited by 154
Coloff, J. L., Macintyre, A. N., Nichols, A., Liu, T., Gallo, C. A., Plas, D. R., & Rathmell, J. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4531 · Cited by 151
Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27
Hsu, H., Lin, J.-H., Huang, W., Hsu, T., Su, K., Chiou, S., Tsai, Y.-T., & Hung, S. (2010) · Cancer · doi:10.1002/cncr.25599 · Cited by 145
Wang, L., Liu, X., Ren, Y., Zhang, J., Chen, J., Zhou, W., Guo, W., Wang, X., Chen, H., Li, M., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.409 · Cited by 142
Yang, S., Irani, K., Heffron, S. E., Jurnak, F., & Meyskens, F. L. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0229 · Cited by 141
Crea, F., Nobili, S., Paolicchi, E., Perrone, G., Napoli, C., Landini, I., Danesi, R., & Mini, E. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.08.001 · Cited by 137
THE CHEMISTRY AND BIOCHEMISTRY OF PURINE ANALOGS
Hitchings, G. H., & Elion, G. B. (1954) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1954.tb40008.x · Cited by 136
Campbell, K. J., Bath, M. L., Turner, M. L., Vandenberg, C. J., Bouillet, P., Metcalf, D., Scott, C. L., & Cory, S. (2010) · Blood · doi:10.1182/blood-2010-04-281071 · Cited by 134
Zhang, N., Qi, Y., Wadham, C., Wang, L., Warren, A., Di, W. J., & Xia, P. (2010) · Autophagy · doi:10.4161/auto.6.8.13614 · Cited by 134
Liu, M. X., Siu, M. K., Liu, S. S., Yam, J. W., Ngan, H. Y., & Chan, D. W. (2014) · Oncotarget · doi:10.18632/oncotarget.1458 · Cited by 131
Zhang, Y., Cheng, Y., Ren, X., Zhang, L., Yap, K. L., Wu, H., Patel, R., Liu, D., Qin, Z.-H., Shih, I.-M., et al. (2012) · Oncogene · doi:10.1038/onc.2011.290 · Cited by 129
Strik, H., Deininger, M., Streffer, J., Grote, E., Wickboldt, J., Dichgans, J., Weller, M., & Meyermann, R. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.6.763 · Cited by 129
Autophagy facilitates the progression of ERα-positive breast cancer cells to antiestrogen resistance
Schoenlein, P. V., Periyasamy-Thandavan, S., Samaddar, J. S., Jackson, W. H., & Barrett, J. T. (2009) · Autophagy · doi:10.4161/auto.5.3.7784 · Cited by 126
Liu, T., Xu, F., Du, X., Lai, D., Liu, T., Zhao, Y., Huang, Q. M., Jiang, L., Huang, W., Cheng, W., et al. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0426-5 · Cited by 126
Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers.
Yang, Y., Liu, H., Li, Z., Zhao, Z., Yip-Schneider, M., Fan, Q., Schmidt, C. M., Chiorean, E. G., Xie, J., Cheng, L., et al. (2011) · PubMed · Cited by 124
Dash, R., Azab, B., Quinn, B. A., Shen, X., Wang, X.-Y., Das, S. K., Rahmani, M., Wei, J., Hedvat, M., Dent, P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100769108 · Cited by 123
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
Dalvi, M. P., Wang, L., Zhong, R., Kollipara, R. K., Park, H., Bayo, J., Yenerall, P. M., Zhou, Y., Timmons, B. C., Rodriguez‐Canales, J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.077 · Cited by 123
Naik, E., Michalak, E. M., Villunger, A., Adams, J. M., & Strasser, A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200608070 · Cited by 121
Guo, W., Lasky, J. L., & Wu, H. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000203592.04530.06 · Cited by 120
Brotin, É., Meryet‐Figuière, M., Simonin, K., Duval, R. E., Villedieu, M., Leroy‐Dudal, J., Saison-Behmoaras, E., Gauduchon, P., Denoyelle, C., & Poulain, L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24787 · Cited by 120
Intrinsic or acquired drug resistance and metastasis: Are they linked phenotypes?
Kerbel, R. S., Kobayashi, H., & Graham, C. H. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240560108 · Cited by 118
Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
Deng, J., Wang, L., Chen, H., Hao, J., Ni, J., Chang, L., Duan, W., Graham, P., & Li, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9908 · Cited by 115
Triller, N., Korošec, P., Kern, I., Košnik, M., & Debeljak, A. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.06.019 · Cited by 115
He, X., Wang, J., Wei, W., Shi, M., Xin, B., Zhang, T., & Shen, X. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1139228 · Cited by 114
Saha, S., Mukherjee, S., Khan, P., Kajal, K., Mazumdar, M., Manna, A., Mukherjee, S., De, S., Jana, D., Sarkar, D. K., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1360 · Cited by 113
The Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and Treatment
Elkholi, R., Floros, K. V., & Chipuk, J. E. (2011) · Genes & Cancer · doi:10.1177/1947601911417177 · Cited by 111
Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance
Andugulapati, S. B., Udupa, N., Chamallamudi, M. R., Gupta, V., & Rangarajan, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155013 · Cited by 111
Regulation of Bcl2 Phosphorylation and Potential Significance for Leukemic Cell Chemoresistance
Deng, X., Kornblau, S. M., Ruvolo, P. P., & May, W. S. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024254 · Cited by 110
Zhang, Y., Xu, W., Guo, H., Zhang, Y., He, Y., Lee, S. H., Song, X., Li, X., Guo, Y., Zhao, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1633 · Cited by 108
Okamoto, K., Miyoshi, K., & Murawaki, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077623 · Cited by 108
Bcl-2 Mediates Chemoresistance in Matched Pairs of Primary Eμ-myc Lymphomas in Vivo
Schmitt, C. A., & Lowe, S. W. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0372 · Cited by 105
Understanding the colon cancer stem cells and perspectives on treatment
Garza-Treviño, E. N., Said‐Fernández, S., & Martínez-Rodríguez, H. G. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0163-7 · Cited by 104
Lestini, B. J., Goldsmith, K. C., Fluchel, M. N., Liu, X., Chen, N., Goyal, B., Pawel, B., & Hogarty, M. D. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.16.8964 · Cited by 100
Dai, Y., Jin, S., Li, X., & Wang, D. (2016) · Oncotarget · doi:10.18632/oncotarget.13817 · Cited by 98
Morales, A. A., Olsson, A., Celsing, F., Österborg, A., Jondal, M., & Osorio, L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20614 · Cited by 95
Autophagy Control by the VEGF-C/NRP-2 Axis in Cancer and Its Implication for Treatment Resistance
Stanton, M. J., Dutta, S., Zhang, H., Polavaram, N. S., Leontovich, A. A., Hönscheid, P., Sinicrope, F. A., Tindall, D. J., Muders, M. H., & Datta, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3635 · Cited by 93
Menéndez, J. A., Vellón, L., & Lupu, R. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.09.027 · Cited by 93
Bose, D., Zimmerman, L. J., Pierobon, M., Petricoin, E. F., Tozzi, F., Parikh, A., Fan, F., Dallas, N. A., Xia, L., Gaur, P., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.449 · Cited by 92
Menéndez, J. A., Lupu, R., & Colomer, R. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000018409.59448.60 · Cited by 90
Wasserheit, C., Frazein, A., Oratz, R., Sorich, J., Downey, A., Hochster, H., Chachoua, A., Wernz, J., Zeleniuch-Jacquotte, A., Blum, R., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.1993 · Cited by 88
The Evolving, Multifaceted Roles of Autophagy in Cancer
Liu, J., & Debnath, J. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.01.005 · Cited by 86
Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Oral Cancer
Wang, L., Mosel, A., Oakley, G. G., & Peng, A. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0448 · Cited by 86
Metformin and prostate cancer stem cells: a novel therapeutic target
Mayer, M., Klotz, L. H., & Venkateswaran, V. K. (2015) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2015.35 · Cited by 86
Efficient Elimination of Cancer Cells by Deoxyglucose-ABT-263/737 Combination Therapy
Yamaguchi, R., Janssen, E. M., Perkins, G. A., Ellisman, M. H., Kitada, S., & Reed, J. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024102 · Cited by 85
Varin, E., Denoyelle, C., Brotin, É., Meryet‐Figuière, M., Giffard, F., Abeilard, E., Goux, D., Gauduchon, P., Icard, P., & Poulain, L. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq026 · Cited by 83
ABCC3 as a marker for multidrug resistance in non-small cell lung cancer
Zhao, Y., Lu, H., An, Y., Yang, Y., Meng, Q., Sun, L., Pang, H., Li, C., Dong, X., & Cai, L. (2013) · Scientific Reports · doi:10.1038/srep03120 · Cited by 80
MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression
Chen, W., Yang, Y.-J., Zhang, Z., An, Q., Li, N., Liu, W., & Yang, B. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-016-0301-4 · Cited by 80
MCL‐1ES, a novel variant of MCL‐1, associates with MCL‐1L and induces mitochondrial cell death
Kim, J.-H., Sim, S., Ha, H., Ko, J., Lee, K., & Bae, J. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.08.006 · Cited by 79
Dash, R., Richards, J. E., Su, Z.-Z., Bhutia, S. K., Azab, B., Rahmani, M., Dasmahapatra, G. P., Yacoub, A., Dent, P., Dmitriev, I. P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0563 · Cited by 77
A set of NF-κB–regulated microRNAs induces acquired TRAIL resistance in Lung cancer
Jeon, Y.-J., Middleton, J. D., Kim, T., Laganà, A., Piovan, C., Secchiero, P., Nuovo, G. J., Cui, R., Joshi, P., Romano, G., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504630112 · Cited by 77
MCL-1 dependency of cisplatin-resistant cancer cells
Michels, J., Obrist, F., Vitale, I., Lissa, D., Garcia, P., Behnam‐Motlagh, P., Kohno, K., Wu, G. S., Brenner, C., Castedo, M., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.029 · Cited by 77
MDR1/P-glycoprotein expression in colorectal cancer
Linn, S., & Giaccone, G. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00278-q · Cited by 76
Zarogoulidis, P., Petanidis, S., Kioseoglou, E., Domvri, K., Anestakis, D., & Zarogoulidis, P. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.009 · Cited by 75
Zalcberg, J. R., Xf, H., Slater, A., Parisot, J. P., El‐Osta, A., Kantharidis, P., St, C., & Parkin, J. D. (2000) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500394 · Cited by 73
Matsuoka (1992) · International Journal of Oncology · doi:10.3892/ijo_00000153 · Cited by 73
Azuma, Y., Yokobori, T., Mogi, A., Altan, B., Yajima, T., Kosaka, T., Onozato, R., Yamaki, E., Asao, T., Nishiyama, M., et al. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23975 · Cited by 72
Olsson, A., Norberg, M., Ökvist, A., Derkow, K., Choudhury, A., Tobin, G., Celsing, F., Österborg, A., Rosenquist, R., Jondal, M., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603951 · Cited by 70
Kumar, B., Yadav, A., Lang, J. C., Teknos, T. N., & Kumar, P. (2015) · Genes & Cancer · doi:10.18632/genesandcancer.54 · Cited by 69
Vazquez-Martin, A., Ropero, S., Brunet, J., Colomer, R., & Menéndez, J. A. (2007) · Oncology Reports · doi:10.3892/or.18.4.973 · Cited by 67
Effect of dual inhibition of apoptosis and autophagy in prostate cancer
Saleem, A., Dvorzhinski, D., Santanam, U., Mathew, R., Bray, K., Stein, M. N., White, E. P., & DiPaola, R. S. (2012) · The Prostate · doi:10.1002/pros.22487 · Cited by 66
Chen, B., Zhang, D., Kuai, J., Cheng, M., Fang, X., & Li, G. (2017) · Tumor Biology · doi:10.1177/1010428317715155 · Cited by 63
Evolving Strategies for Therapeutically Targeting Cancer Stem Cells
Talukdar, S., Emdad, L., Das, S. K., Sarkar, D., & Fisher, P. B. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.04.003 · Cited by 63
Mcl-1 is an important therapeutic target for oral squamous cell carcinomas
Maji, S., Samal, S. K., Pattanaik, L., Panda, S., Quinn, B. A., Das, S. K., Sarkar, D., Pellecchia, M., Fisher, P. B., & Dash, R. (2015) · Oncotarget · doi:10.18632/oncotarget.3932 · Cited by 63
Liu, C., Li, Z., Bi, L., Li, K., Zhou, B., Chen, X., Huang, J., & Xu, K. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2069-4 · Cited by 63
Kim, D. W., Kim, K. O., Shin, M., Ha, J. H., Seo, S. W., Yang, J., & Lee, F. Y. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-28 · Cited by 63
Li, H., Jin, X., Zhang, Z., Xing, Y., & Kong, X. (2012) · Cell Biochemistry and Function · doi:10.1002/cbf.2917 · Cited by 62
Cancer Stem Cells in Prostate Cancer Chemoresistance
Ni, J., Cozzi, P. J., Hao, J., Duan, W., Graham, P., Kearsley, J. H., & Li, Y. (2014) · Current Cancer Drug Targets · doi:10.2174/1568009614666140328152459 · Cited by 62
Sakamoto, T., Kobayashi, S., Yamada, D., Nagano, H., Tomokuni, A., Tomimaru, Y., Noda, T., Gotoh, K., Asaoka, T., Wada, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145985 · Cited by 59
Chen, H., Zhang, W., Cheng, X., Guo, L., Xie, S., Ma, Y.-F., Guo, N., & Shi, M. (2017) · Cancer Science · doi:10.1111/cas.13275 · Cited by 58
Skubisz, M. M., & Tong, S. (2012) · ISRN Obstetrics and Gynecology · doi:10.5402/2012/637094 · Cited by 57
Yang, J., Zhang, K., Wu, J. H., Shi, J., Xue, J., Li, J., Chen, J., Zhu, Y., Wei, J., He, J., et al. (2016) · Stem Cells International · doi:10.1155/2016/1690896 · Cited by 57
Osaki, S., Tazawa, H., Hasei, J., Yamakawa, Y., Omori, T., Sugiu, K., Komatsubara, T., Fujiwara, T., Sasaki, T., Kunisada, T., et al. (2016) · Scientific Reports · doi:10.1038/srep28953 · Cited by 57
Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells
McIntosh, K., Balch, C., & Tiwari, A. K. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1179280 · Cited by 55
Liao, M., Zhao, J., Wang, T., Duan, J., Zhang, Y., & Deng, X. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-44 · Cited by 54
Schneider, J., González-Roces, S., Pollán, M., Lucas, R., Tejerina, A., Martín, M., & Alba, A. (2001) · Breast Cancer Research · doi:10.1186/bcr293 · Cited by 53
Mucin 1-mediated chemo-resistance in lung cancer cells
Ham, S. Y., Kwon, T., BAK, Y., Yu, J.-H., Hong, J. T., Lee, S. K., Yu, D.-Y., & Yoon, D.-Y. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.47 · Cited by 53
Zhao, L., Ren, Y.-X., Tang, H., Wang, W., He, Q., Sun, J., Zhou, X. C., & Wang, A. (2015) · Oncotarget · doi:10.18632/oncotarget.6253 · Cited by 53
Nishioka, T., Luo, L.-Y., Shen, L., He, H., Mariyannis, A., Dai, W. H., & Chen, C. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.78 · Cited by 51
Barile, E., Marconi, G. D., De, S. K., Baggio, C., Gambini, L., Salem, A. F., Kashyap, M. K., Castro, J. E., Kipps, T. J., & Pellecchia, M. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00962 · Cited by 51
Zhao, Q., Cao, J., Wu, Y., Liu, X., Han, J., Huang, X., Jiang, L., Hou, X., Mao, W., & Ling, Z. (2015) · Europe PMC (PubMed Central) · Cited by 50
Zhao, Y., Zhang, C.-L., Zeng, B.-F., Wu, X.-S., Gao, T.-T., & Oda, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.020 · Cited by 50
Targeting Base Excision Repair for Chemosensitization
Adhikari, S., Choudhury, S., Mitra, P. S., Dubash, J., Sajankila, S. P., & Roy, R. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008784220366 · Cited by 49
Overexpression of lncRNA NEAT1 mitigates multidrug resistance by inhibiting ABCG2 in leukemia
Gao, C., Zhang, J., Wang, Q., & Ren, C. (2016) · Oncology Letters · doi:10.3892/ol.2016.4738 · Cited by 49
Observations on the anticancer activity of 6-mercaptopurine.
He, S., Thomson, Elion, G. B., & Hitchings, G. H. (1954) · PubMed · Cited by 49
Meynet, O., Bénéteau, M., Jacquin, M. A., Pradelli, L. A., Cornille, A., Carlès, M., & Ricci, J. (2011) · Leukemia · doi:10.1038/leu.2011.327 · Cited by 48
Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar
Sun, Y.-L., Chen, J.-J., Kumar, P., Chen, K., Sodani, K. S., Patel, A. S., Chen, Y., Chen, S.-D., Jiang, W.-Q., & Chen, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055576 · Cited by 47
The Efflux Transporter ABCG2 Maintains Prostate Stem Cells
Sabnis, N. G., Miller, A., Titus, M. A., & Huss, W. J. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0270-t · Cited by 45
Habata, S., Iwasaki, M., 杉尾, 明., Suzuki, M., Tamate, M., Satohisa, S., Tanaka, R., & Saito, T. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3494 · Cited by 45
Epigenetic therapy and chemosensitization in solid malignancy
Ronnekleiv‐Kelly, S. M., Sharma, A. R., & Ahuja, N. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.03.008 · Cited by 43
Liu, Y., Gao, S., Chen, X., Liu, M., Mao, C., & Fang, X. (2016) · Tumor Biology · doi:10.1007/s13277-016-5066-2 · Cited by 41
田淵, 陽. (2009) · Institutional Repositories DataBase (IRDB) · Cited by 40
Zhou, J., Deng, X., He, X., ZHOU, Y., Yu, M., Gao, W., ZENG, B., Zhou, Q., Li, Z., & Chen, R. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2347 · Cited by 38
Expression of a novel Bcl-2 related gene, Bfl-1, in various human cancers and cancer cell lines.
Park, I. C., Lee, S.-H., Whang, D. Y., Hong, W.-S., Choi, S. S., Shin, H., Choe, T., & Hong, S.-I. (1997) · PubMed · Cited by 37
Çaçan, E. (2017) · Cell Biology International · doi:10.1002/cbin.10729 · Cited by 35
Choi, B. Y., Joo, J. C., Lee, Y. K., Jang, I., Park, S.-J., & Park, Y. J. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1776-2 · Cited by 34
FKBP38-Bcl-2 interaction: a novel link to chemoresistance
Choi, B., & Yoon, H. S. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.04.013 · Cited by 31
Morgan, R. J., Braly, P. D., Leong, L., Shibata, S., Margolin, K. A., Somlo, G., McNamara, M., Longmate, J., Schinke, S., Raschko, J. W., et al. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5793 · Cited by 23
Chiang, Y., Chang, M.-C., Chen, P., Wu, M., Hsieh, C., Cheng, W., & Chen, C. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0117 · Cited by 22
Nuclear translocation of MRP1 contributes to multidrug resistance of mucoepidermoid carcinoma
Cai, B., Xu, X.-F., Fu, S., Shen, L., Zhang, J., Guan, S., & Wu, J. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.08.005 · Cited by 21
Viana, L. D. S., Silva, F. C. D. A., Jacome, A. A. D. A., Maia, D. C. C., de Mattos, M. D., Jacinto, A. A., Mamere, A. E., Boldrini, D., Capuzzo, R. D. C., dos Santos, C. R., et al. (2015) · Head & Neck · doi:10.1002/hed.24137 · Cited by 16
Methylation of Notch3 modulates chemoresistance via P-glycoprotein
Gu, X., Lu, Y., He, D., Lu, C., Jin, J., Lu, X., & Ma, X. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.024 · Cited by 4
Cited by
The role of BCL-2 family proteins in regulating apoptosis and cancer therapy
Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., & Wang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.985363 · Cited by 1,011
Hwang, W. L., Jagadeesh, K. A., Guo, J. A., Hoffman, H. I., Yadollahpour, P., Reeves, J. W., Mohan, R., Drokhlyansky, E., Van Wittenberghe, N., Ashenberg, O., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01134-8 · Cited by 426
Advances in phytochemical delivery systems for improved anticancer activity
Lagoa, R., Silva, J., Rodrigues, J. R., & Bishayee, A. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.04.004 · Cited by 214
Basu, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107943 · Cited by 171
Metadata
- Venue
- Advances in Cancer Research
- Publisher
- Elsevier
- Published
- 2018
- Volume
- 137
- Pages
- 37-75
- ISSN
- 0065-230X (ISSN-L)
- OpenAlex
- W2773539874
- Cited by
- 215
- References
- 190
- FWCI
- 17.70
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.